Stryker completes acquisition of ZuriMED to enhance its shoulder offering
Key Highlights
- ➤Stryker (SYK) completes acquisition of ZuriMED
- ➤FiberLocker System adds commercialized rotator cuff augmentation technology
- ➤Acquisition expands Stryker’s shoulder care and sports medicine portfolio
Expert Statements
Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker
“ZuriMED brings specialized expertise and a differentiated technology that complements our growing shoulder care capabilities.”
Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker
“Together, we have an opportunity to advance the FiberLocker technology, expand access to innovative treatment options and deliver greater value for our customers and their patients.”
Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- * Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System to its Sports Medicine portfolio * The acquisition adds a commercialized rotator cuff augmentation technology to Stryker’s shoulder portfolio * The addition expands Stryker’s ability to support shoulder specialists across sports medicine and shoulder care Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and developer of the FiberLocker(®) System.
The FiberLocker System is a commercialized rotator cuff augmentation technology designed to increase the biomechanical strength of the repair. The differentiated technology addresses an important clinical need in rotator cuff repair and expands Stryker’s ability to support shoulder surgeons with innovative solutions across the shoulder continuum of care.
Get started
Create a free account to read the full story.